Subsense emerged from stealth in February 2025 and is developing a nanoparticle-based brain-computer interface (BCI).

Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

In the ever-evolving landscape where technology intersects with healthcare, Brain-Computer Interfaces (BCIs) are emerging as a transformative force, turning the once-fantastic imaginings of science ...

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Neuralink announced that it appointed FDA executive David McMullen to lead medical affairs as it advances its brain-computer ...

Subsense, Inc., a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 ...

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports ...